• C Montagner, A Bricou, F Selle, H Kafé, W Mauhin, L Fredeau, L Duval-Chopard, J Slama, P Durand, C Beal, J London, and O Lidove.
• Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France. Electronic address: cmontagner@hopital-dcss.org.
• Rev Med Interne. 2019 Nov 1; 40 (11): 754-757.

IntroductionCervical cancer is the twelfth most frequent cancer in women in France. Glassy cell carcinoma is a rare histological entity, rapidly aggressive, associated with a poor prognosis.Case ReportA 30-year-old woman was admitted in an internal medicine department for polyarthralgia with high grade fever, evolving for 3 weeks. There was an inflammatory syndrome. The 18-FDG-PET-scan showed inflammatory lymph nodes as well as disseminated osteolytic lesions, and a primitive pelvic tumor. A 3cm tumor of the cervix was found during the gynaecologic examination. Histological analysis elicited a high-index mitotic carcinoma, glassy cell carcinoma type. Despite chemotherapy, the outcome was poor, with early death occurring after three months of follow-up.ConclusionThe glassy cell carcinoma of the cervix should be considered as an aetiology of bone metastases in young female patients.Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

17 keywords...

hide…